KLOW Stack (BPC-157, TB-500, GHK-Cu, KPV) 10/10/50/10mg — Research Compound

KLOW Stack (BPC-157, TB-500, GHK-Cu, KPV) (10/10/50/10mg) — Research Compound

KLOW is an expanded research blend combining BPC-157, TB-500, GHK-Cu, and KPV. Building on the established repair and collagen-focused pathways of the Glow formulation, this combination introduces an additional focus on inflammatory and immune signalling. BPC-157 interacts with nitric oxide and growth factor pathways, while TB-500 (Thymosin Beta-4) influences actin polymerisation for cell migration. GHK-Cu, a copper-binding peptide, is studied for its role in gene expression linked to skin remodelling and DNA repair. KPV, a tripeptide fragment of alpha-MSH, is studied for its involvement in cytokine regulation and inflammatory pathway modulation across multiple biological systems.

Findings from early-stage clinical and preclinical research have reported:

• Accelerated healing of tendons, ligaments, and dermal tissue observed in experimental models
  
• Significant increases in collagen production and angiogenesis reported at injury sites
  
• Reductions in systemic and localised inflammatory markers noted across multiple study cohorts
  
• Suppression of pro-inflammatory cytokines such as TNF-α and IL-6 observed in KPV-related studies, particularly in gut and skin models

Researchers study the KLOW Stack to investigate the interaction between angiogenic, regenerative, and inflammatory-modulating peptides within a single system. The inclusion of KPV extends the scope beyond structural repair into immune signalling pathways, allowing for broader investigation into tissue recovery under inflammatory stress conditions. This blend serves as a model for examining the relationship between repair signalling, collagen synthesis, and cytokine regulation.

Available Formats:
This compound is available as a vial of lyophilised powder, or can be ordered in a disposable pen, a reusable pen, or a cartridge for an existing reusable pen system.

Used solely for in vitro experiments and cannot be:

• Used in clinical trials involving humans
• Administered to humans as part of an experiment or investigation
• Supplied to another party for human investigational use